Reviewed,
UniProtKB/Swiss-Prot P20749 (BCL3_HUMAN)
Last modified
June 16, 2009.
Version 94.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: B-cell lymphoma 3-encoded protein Short name=Protein Bcl-3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 446 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Could be a transcriptional activating factor. Functions as a form of I-kappa-B specific for NF-kappa-B p50 subunit inhibiting its translocation to the nucleus. Ref.4 |
| Subunit structure | Component of a complex consisting of the NF-kappa-B p52-p52 homodimer and BCL3. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Interacts with N4BP2 and COPS5. Ref.6 Ref.7 |
| Subcellular location | |
| Post-translational modification | Activated by phosphorylation. |
| Involvement in disease | A chromosomal aberration involving BCL3 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(14;19)(q32;q13.1) with immunoglobulin gene regions. |
| Sequence similarities | Contains 7 ANK repeats. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 446 | 446 | B-cell lymphoma 3-encoded protein | PRO_0000066976 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Repeat | 126 – 155 | 30 | ANK 1 | ||||||||||||||||||||||||||||||||||||
| Repeat | 163 – 192 | 30 | ANK 2 | ||||||||||||||||||||||||||||||||||||
| Repeat | 196 – 227 | 32 | ANK 3 | ||||||||||||||||||||||||||||||||||||
| Repeat | 233 – 262 | 30 | ANK 4 | ||||||||||||||||||||||||||||||||||||
| Repeat | 267 – 296 | 30 | ANK 5 | ||||||||||||||||||||||||||||||||||||
| Repeat | 300 – 329 | 30 | ANK 6 | ||||||||||||||||||||||||||||||||||||
| Repeat | 330 – 359 | 30 | ANK 7 | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 1 – 112 | 112 | Pro-rich | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 357 – 446 | 90 | Pro/Ser-rich | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 394 | 1 | Phosphoserine; by GSK3 Ref.9 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 398 | 1 | Phosphoserine; by GSK3 Ref.9 | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Helix | 130 – 136 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 140 – 152 | 13 | |||||||||||||||||||||||||||||||||||||
| Helix | 167 – 173 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 177 – 185 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 200 – 206 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 210 – 219 | 10 | |||||||||||||||||||||||||||||||||||||
| Helix | 237 – 244 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 247 – 255 | 9 | |||||||||||||||||||||||||||||||||||||
| Turn | 265 – 267 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 271 – 277 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 281 – 289 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 304 – 311 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 314 – 322 | 9 | |||||||||||||||||||||||||||||||||||||
| Turn | 337 – 340 | 4 | |||||||||||||||||||||||||||||||||||||
| Helix | 344 – 350 | 7 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control." Ohno H., Takimoto G., McKeithan T.W. Cell 60:991-997(1990) [PubMed: 2180580] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [3] | "Genomic structure of the candidate proto-oncogene BCL3." McKeithan T.W., Ohno H., Dickstein J., Hume E. Genomics 24:120-126(1994) [PubMed: 7896265] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 79-446. Tissue: Leukemia. |
| [4] | "The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers." Bours V., Franzoso G., Azarenko V., Park S., Kanno T., Brown K., Siebenlist U. Cell 72:729-739(1993) [PubMed: 8453667] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN A COMPLEX WITH NFKB2/P52. |
| [5] | "NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes." Heissmeyer V., Krappmann D., Wulczyn F.G., Scheidereit C. EMBO J. 18:4766-4778(1999) [PubMed: 10469655] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH NFKB1/P50. |
| [6] | "The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators." Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F.G., Scheidereit C., Leutz A. Oncogene 18:3316-3323(1999) [PubMed: 10362352] [Abstract] Cited for: INTERACTION WITH COPS5. |
| [7] | "Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination." Watanabe N., Wachi S., Fujita T. J. Biol. Chem. 278:26102-26110(2003) [PubMed: 12730195] [Abstract] Cited for: INTERACTION WITH N4BP2. |
| [8] | "Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family." Michel F., Soler-Lopez M., Petosa C., Cramer P., Siebenlist U., Muller C.W. EMBO J. 20:6180-6190(2001) [PubMed: 11707390] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 119-359. |
| [9] | "GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity." Viatour P., Dejardin E., Warnier M., Lair F., Claudio E., Bureau F., Marine J.C., Merville M.P., Maurer U., Green D., Piette J., Siebenlist U., Bours V., Chariot A. Mol. Cell 16:35-45(2004) [PubMed: 15469820] [Abstract] Cited for: PHOSPHORYLATION AT SER-394 AND SER-398. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M31731 Genomic DNA. Translation: AAA51816.1. M31732 mRNA. Translation: AAA51815.1. BC064993 mRNA. Translation: AAH64993.1. U05681, U05822 Genomic DNA. Translation: AAC51348.1. | |||||||||||||||||||
| IPI | IPI00791379. | ||||||||||||||||||
| PIR | A34794. | ||||||||||||||||||
| RefSeq | NP_005169.2. | ||||||||||||||||||
| UniGene | Hs.31210 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P20749. 1 interaction. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P20749. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | P20749. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000069399. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 602. | ||||||||||||||||||
| KEGG | hsa:602. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| GeneCards | GC19P049943. | ||||||||||||||||||
| H-InvDB | HIX0040117. | ||||||||||||||||||
| HGNC | HGNC:998. BCL3. | ||||||||||||||||||
| HPA | CAB002051. | ||||||||||||||||||
| MIM | 109560. gene. | ||||||||||||||||||
| PharmGKB | PA25310. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOGENOM | P20749. | ||||||||||||||||||
| HOVERGEN | P20749. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | nfkappabatypicalpathway. Atypical NF-kappaB pathway. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P20749. | ||||||||||||||||||
| Bgee | P20749. | ||||||||||||||||||
| CleanEx | HS_BCL3. | ||||||||||||||||||
| GermOnline | ENSG00000069399. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR002110. ANK. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:1.25.40.20. ANK. 1 hit. | ||||||||||||||||||
| Pfam | PF00023. Ank. 7 hits. [Graphical view] | ||||||||||||||||||
| SMART | SM00248. ANK. 6 hits. [Graphical view] | ||||||||||||||||||
| PROSITE | PS50297. ANK_REP_REGION. 1 hit. PS50088. ANK_REPEAT. 5 hits. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| NextBio | 2447. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | BCL3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P20749 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


